SEC Form 4 · accession 0001437749-15-017691
BIOLARGO, INC. · BLGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kenneth Reay Code
Officer — Chief Science Officer · Director · 10% Owner
Period of report
Sep 22, 2015
Accepted (ET)
Sep 24, 2015 · 3:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000880242
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Sep 22, 2015 | A | 69,618 | — | A | 24,753,707 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are restricted from sale until the earlier of (i) Reporting Person's employment with Issuer is terminated, or (ii) the Issuer reports a "change in control" on Form 8-K.
- F2These shares were issued to Reporting Person as payment for $45,251.68 in fees due to Reporting Person for services as Issuer's Chief Science Officer, pursuant to a plan adopted by the Issuer's Board to retire outstanding accounts payable. Share number is net of 69,618 shares issued September 22, 2015 as a result of a clerical error.
- F3Includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.